Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Quant Analyst PlanB Says Bitcoin Now at Point of ‘No Return,’ Similar to 2020, 2017 and 2013 Bull Markets

Quant Analyst PlanB Says Bitcoin Now at Point of ‘No Return,’ Similar to 2020, 2017 and 2013 Bull Markets

Daily HodlDaily Hodl2025/09/29 16:00
By:by Daily Hodl Staff

A popular crypto analyst thinks the Bitcoin ( BTC ) bull market isn’t over yet.

The pseudonymous trader PlanB tells his 2.1 million X followers that BTC has passed the “point of no return.”

“I think [the] Bitcoin bull market has not ended and will continue. I don’t know until when, or how high. It could also be a long, steady uptrend, without FOMO+crash. IMO, we passed the point of no return (yellow dots) in June 2025, similar to October 2020, February 2017 and January 2013.” 

Quant Analyst PlanB Says Bitcoin Now at Point of ‘No Return,’ Similar to 2020, 2017 and 2013 Bull Markets image 0 Source: PlanB/X

PlanB also shares a graph of the stock-to-flow model, a predictive tool that assumes the scarcity of a commodity drives its price.

“Whether you like it or not, Bitcoin’s value is very much linked to its scarcity. Fiat will be printed, Bitcoin will rise.”

Quant Analyst PlanB Says Bitcoin Now at Point of ‘No Return,’ Similar to 2020, 2017 and 2013 Bull Markets image 1 Source: PlanB/X

 

While the stock-to-flow model was originally created to track traditional commodities, PlanB was one of the first analysts to apply it to Bitcoin.

Earlier this month, the crypto analyst argued that all asset prices – including gold, BTC, and the S&P 500 – have been rising during the last decade due to the Fed printing money.

“How will there be diminishing returns when debasement is exponential? All asset prices increased exponentially last 10 years (driven by money printing): -Gold 3x (~$1,000 to ~$3,000) -S&P 3x (~$2,000 to ~$6,000) -Bitcoin 250x (~$400 to ~$100,000). In my opinion, it is a unit of account phenomenon.”

BTC is trading at $114,471 at time of writing. The top-ranked crypto asset by market cap is up nearly 2% in the past 24 hours.

Generated Image: Midjourney

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

BCH has surged by 35.79% since the beginning of the year, reflecting the overall positive sentiment in the market.

- Bitcoin Cash (BCH) fell 0.1% in 24 hours but rose 35.79% year-to-date, outperforming peers. - Sustained 7-day (7.55%) and 1-month (9.1%) gains highlight growing institutional and retail confidence. - Market adoption in DeFi and low-cost transactions, plus macroeconomic optimism, drive BCH's long-term appeal. - Analysts predict continued growth as BCH's ecosystem matures and on-chain activity rises.

Bitget-RWA2025/12/04 01:04

Solana's Sharp Drop: Causes Behind the Fall and Future Prospects for Investors

- Solana's 30% price drop in late 2025 contrasts with strong on-chain metrics like 400ms finality and $35.9B DEX volume, but declining user engagement and rising NVT ratios signaled overvaluation. - Macroeconomic factors including high interest rates and institutional caution reduced speculative demand, with ETF inflows favoring staking products over direct price support. - Whale accumulation and RWA growth (up 350% YoY) suggest strategic buying during dips, though active address recovery and NVT normaliza

Bitget-RWA2025/12/04 00:54
Solana's Sharp Drop: Causes Behind the Fall and Future Prospects for Investors

The Increasing Expenses of Dementia Treatment and Their Influence on Healthcare Investment Prospects

- Global dementia cases surge to 55M in 2025, projected to triple to 139M by 2050 due to aging populations and Alzheimer's rise. - U.S. dementia costs hit $781B in 2025, with Medicare/Medicaid covering $164B and families paying $52B out-of-pocket. - Home healthcare and AI caregiver tech markets grow rapidly (10-17% CAGR), reaching $381B and $5.3B by 2033-2032 respectively. - Dementia biotech faces risks but attracts $3.1B in Q3 2025 venture funding (+70.9% QoQ), despite $161M losses at Alector/Denali. - St

Bitget-RWA2025/12/04 00:38
The Increasing Expenses of Dementia Treatment and Their Influence on Healthcare Investment Prospects
© 2025 Bitget